Cargando…
Ex Vivo Human Placental Transfer of Anti-Human Immunodeficiency Virus Compounds
Objective: The transfer of anti-human immunodeficiency virus (HIV) drugs has been studied in the ex vivo human placental model. There is a paucity of information on the placental transfer of these drugs because of ethical considerations and the expense involved in the use of the non-human primate mo...
Autor principal: | Bawdon, Roger E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364554/ https://www.ncbi.nlm.nih.gov/pubmed/18476157 http://dx.doi.org/10.1155/S1064744997000537 |
Ejemplares similares
-
Ex vivo human placental transfer of trovafloxacin.
por: Casey, B, et al.
Publicado: (2000) -
Ex Vivo Human Placental Transfer of Rifampin and Rifabutin
por: Magee, Kevin P., et al.
Publicado: (1996) -
The ex vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavir.
por: Bawdon, R E
Publicado: (1998) -
Transfer of meropenem in the ex vivo human placenta perfusion model.
por: Hnat, Michael, et al.
Publicado: (2005) -
The Bidirectional Transfer and Fetal Vascular Pressure Changes
Due to the Presence of [Formula: see text] I-Labeled Inhibin A in the ex-vivo
Human Placental Model
por: Bawdon, Roger E., et al.
Publicado: (2003)